Stable Atrial Fibrilation

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 1

Stable Atrial Fibrilation :

Distribution, Risk Factor, and


Management Therapy in Koja General
Hospital

Hartono A. A. , Massie G. C. , Nasser N. Y. , Gill R. S. D.


1

Koja General Hospital, Jakarta, Indonesia; 2Kembangan District Hospital, Jakarta,


Indonesia; 3Faculty of Medicine, University of Airlangga, Surabaya, Indonesia; 4Subang
General Hospital, West Java, Indonesia
1

Background
Atrial fibrillation (AF) is an irregular heartbeat (arrhythmia) that can lead to many other heartrelated complications..The treatment goals of AF start with a proper diagnosis through an in-depth
examination from a physician based on the patients history, physical examination, ECG, and also
risk factors. Rhythm control, rate control, prevention of thromboembolism, are recommended for
therapy in AF based on its pathophysiology mechanisms. In what follows, we conclude some of
these risk factors and the underlying mechanisms by which these conditions may contribute to the
development of AF. These underlying factors also may alter the prognosis. Adequate treatment of
reduction of these risk factors possibly may reduce the prevalence of AF and improve prognosis.

Method
A cross-sectional study was done from January May 2016 to 26 patients with stable atrial
fibrillation at Koja General Hospital, Jakarta.

Results

Conclusion

There were 26 patients included in the


study, with mean age 59.79 13.22 and
male : female ratio
1: 1.17. CHF (80.8%)
shows the biggest proportion as risk factor
followed by hypertension (76.9%), coronary
arterial disease (42.3%), valvular disease
(7.7%). Most of patients (38.5%) are given
digoxin followed by beta blockers (34.5%),
ca-channel blockers (17.5%) and amiodarone
(7.7%) as a first line therapy. 34.6% of
patients gets simvastatin and 30.8% gets
anticoagulant as additional therapy.

Keywords

Most patients are man and mostly aged


above 50 years old. Many patients have
CHF followed by hypertension and coronary
arterial disease as the risk factor. Digoxin is
the most used medicine followed by beta
blockers. Some patients get simvastatin
and anticoagulant as preventive therapy.

Atrial fibrillation, Koja General Hospital, Cardiac arrhythmia

You might also like